LGND Key Stats
|Revenue (Quarterly YoY Growth)||104.0%|
|EPS Diluted (TTM)||0.5131|
|EPS Diluted (Quarterly YoY Growth)|
|Net Income (TTM)||10.61M|
|Gross Profit Margin (Quarterly)||80.48%|
|Profit Margin (Quarterly)||15.11%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM) Pro||Go Pro|
- The Best Biotech CEO of 2013 is... The Street Dec 11
- 3:48 am Ligand Pharma provide positive preclinical data on small-molecule G-CSF receptor agonist Dec 9
- Ligand Announces Positive Preclinical Data on Small-Molecule G-CSF Receptor Agonist at the 55th Annual Meeting of the American Society of Hematology noodls Dec 9
- Ligand announces data from preclinical LGD-7455 studies Dec 9
- Keep an Eye on Ligand, Medivation, ChemoCentryx, and Teva Today Fool Dec 4
- LIGAND PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure Dec 4
- Ligand Pharma (LGND) Boosts Q4, FY13 Outlook Street Insider Dec 4
- Ligand Raises Fourth Quarter and Full Year 2013 Financial Forecast Business Wire Dec 4
- Best Biotech CEO of 2013: Your Vote Counts The Street Dec 4
- Insider Trading Alert - NVR, AN, PPS, BRCM And LGND Traded By Insiders The Street Dec 2
LGND Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Ligand Pharmaceuticals is up 174.7% over the last year vs S&P 500 Total Return up 27.53%, Metabasis Therapeutics up 26.25%, and Lannett Company up 464.0%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Balance Sheet View Statement
Pro Ratings for LGND
Pro Report PDF for LGND
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download LGND Pro Report PDF
Pro Strategies Featuring LGND
Did Ligand Pharmaceuticals make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Ligand Pharmaceuticals, Inc., is a biotechnology company that operates with a business model focused on developing or acquiring assets.